Trademark: 79369113
Word
EPIDEX
Status Date
Tuesday, August 13, 2024
Registration Number
7470276
Registration Date
Tuesday, August 13, 2024
Filing Date
Monday, January 9, 2023
Published for Opposition
Tuesday, May 28, 2024
5 Medicines for use in tissue regeneration and wound healing in the management of acute and chronic wounds and rare diseases; enzymes for medical use; pharmaceutical preparations for wound healing in the management of acute and chronic wounds and rare diseases; cells for medical use; living cells for medical use; pharmaceutical preparations containing stem cells for wound healing in the management of acute and chronic wounds and rare diseases; stem cells for medical use; stem cells for veterinary use; transplants being implants comprising living tissue; surgical implants made from living tissues; surgical implants grown from stem cells being living tissue; bone void fillers made from living tissues; tissue-regenerative pharmaceutical preparations; enzymes for veterinary use; all the above mentioned goods not related to the treatment of epilepsy or other neurological disorders
44 Stem cell therapy services; medical services, namely, analysis of human tissues for medical treatment purposes; stem cell bank services for medical transplantation; medical services, namely, the removal, treatment and processing of stem cells; medical services, namely, the removal, treatment and processing of human cells; medical and health care services, namely, DNA screening for medical purposes, genetics counseling and genetic testing for medical purposes; genetic testing for medical use; genetic counseling; regenerative medicine services; medical services in the field of treatment of chronic conditions; medical services in the field of injury healing; all the above-mentioned services not related to the treatment of epilepsy or other neurological disorders
42 Tissue engineering, namely, genetic engineering of human tissue for others; Analysis of human tissues for medical research; scientific research services, namely, the isolation and cultivation of human tissues and cells; genetic engineering services; scientific research in the field of genetics and genetic engineering; advisory services relating to gene therapy research; research in the field of gene therapy; all the above-mentioned services not related to the treatment of epilepsy or other neurological disorders
The mark consists of the light blue stylized wording "EPIDEX" behind a red design of three concentric rectangles. The color white represents background, outlining, shading, and transparent areas and is not claimed as a feature of the mark.
The color(s) light blue and red is/are claimed as a feature of the mark.
May 11, 2023
Sn Assigned For Sect 66a Appl From Ib
May 16, 2023
Application Filing Receipt Mailed
Oct 2, 2023
Assigned To Examiner
Oct 19, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Oct 26, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Nov 13, 2023
Refusal Processed By Ib
Apr 25, 2024
Approved For Pub - Principal Register
Apr 25, 2024
Teas/Email Correspondence Entered
Apr 25, 2024
Correspondence Received In Law Office
Apr 25, 2024
Teas Response To Office Action Received
May 8, 2024
Notification Of Notice Of Publication E-Mailed
May 28, 2024
Published For Opposition
May 28, 2024
Official Gazette Publication Confirmation E-Mailed
Aug 13, 2024
Registered-Principal Register
Aug 13, 2024
Notice Of Registration Confirmation Emailed
May 12, 2023
New Application Office Supplied Data Entered
Oct 18, 2023
Non-Final Action Written
Oct 26, 2023
Refusal Processed By Mpu
Trademark Alertz updated from USPTO on 2030-01-24
